In this VAM review issue:
- Outgoing President Ronald L. Dalman, MD, deals with the challenges of COVID-19 and the future direction of the Society for Vascular Surgery (SVS) head-on in his Presidential Address (p. 1 and 2)
- In the other Presidential Address of the 2021 Vascular Annual Meeting (VAM), Kim Hodgson, MD, tackles inappropriateness in care, asking SVS members to confront the key issue (p. 1 and 10–11)
- ‘Let’s move on to solutions,’ keynote speaker Lee Kirksey, MD, tells a diversity, equity and inclusion (DEI) focus session (p. 1 and 2)
- Significant reintervention after F-BEVAR ‘does not negatively impact survival,’ research presented by Sara L. Zettervall, MD, found (p. 3)
- An analysis conducted by researchers in Texas shows transcarotid revascularization (TCAR) is more cost-effective than carotid artery stenting (CAS) for carotid stenosis, Sheila M. Coogan, MD, told VAM attendees (p. 6)
- ‘The future is very bright for venous valve replacement’ Ellen Dillavou, MD, says during a special session co-hosted by the American Venous Forum (p. 8)
- ‘Tremendous advances in imaging possibilities’ signal further innovation, Matthew Eagleton, MD, advises a VAM digital session (p. 14)
- Elsie Gyang Ross, MD, used her Roy Greenberg Distinguished Lecture to tell delegates about the potential for artificial intelligence (AI) to transform vascular surgery (p. 19)
